Real-time enrollment status for this autosomal dominant polycystic kidney disease (adpkd) clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 8:50 AM UTC
| NCT Number | NCT07454174 |
| Recruiting Status | Recruiting |
| Condition | Autosomal Dominant Polycystic Kidney Disease (ADPKD) |
| Phase | Clinical Trial |
| Target Enrollment | 20 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Richard Fatica |
| Last Updated on CT.gov | March 6, 2026 (Mar 6, 2026) |
As of July 13, 2026: Clinical trial NCT07454174 is currently recruiting participants. This clinical trial study for autosomal dominant polycystic kidney disease (adpkd) is actively seeking new participants at 1 location across the United States. The study is sponsored by Richard Fatica. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07454174 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07454174 was last updated Mar 6, 2026 (March 6, 2026). HelloStudys verifies this status automatically.